Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studies
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (10) , 1406-1410
- https://doi.org/10.1016/0959-8049(93)90012-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancerCancer, 1991
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989
- Initially Unresectable Rectal Adenocarcinoma Treated with Preoperative Irradiation and SurgeryAnnals of Surgery, 1987
- Interactions of radiation and 5-fluorouracil, cyclophosphamide or methotrexate in intestinal crypt cellsInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Residual, unresectable, or recurrent colorectal cancer: External, beam irradiation and intraoperative electron beam boost ± resectionInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X raysInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Reporting results of cancer treatmentCancer, 1981
- COMBINED 5-FLUOROURACIL AND SUPERVOLTAGE RADIATION THERAPY OF LOCALLY UNRESECTABLE GASTROINTESTINAL CANCERThe Lancet, 1969